NCT07866287Not yet recruiting
Finerenone's Impact on Cardiac Electrical Stability in HFpEF
Impact of Finerenone on Cardiac Electrical Stability in Patients With Heart Failure With Preserved Ejection Fraction
Source: ClinicalTrials.gov · Last updated 8 Oct 2026
Brief summary (registry, in English)
To evaluate the efficacy of finerenone in reducing the incidence of any electrical instability or arrhythmias in the form of new-onset atrial fibrillation or atrial flutter (AFF), atrial tachycardia, extrasystoles (premature atrial and ventricular contractions, PACs and PVCs, respectively), ventricular arrhythmias, bradycardia, in patients with heart failure with preserved ejection fraction who are in sinus rhythm.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 10 Sept 2026
- Start date
- 1 Oct 2026
- Primary completion date
- 1 Sept 2027
- Lead sponsor
- Assiut University
- Diseases
- Heart failure, Atrial fibrillation
- NCT number
- NCT07866287
What you commit to
- Study type: Observational
- Planned participants: 100
- From 1 Oct 2026 to the primary completion date, 1 Sept 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Any history of documented atrial fibrillation, atrial flutter, or atrial tachycardia.
- Presence of an implanted cardiac pacemaker or defibrillator with active atrial pacing.
- Severe liver impairment.
Lab values
- Estimated glomerular filtration rate (eGFR)\<25 mL/min/1.73m2 at screening.
- Baseline serum potassium level\>5 mEq/L.
Other
- Presence of conduction abnormalities such as LBBB or RBBB.
- Presence of significant valvular dysfunction.
- Marked electrolyte imbalance.
Who the study is looking for
- Age ≥ 18 years.
- Evidenced heart failure with preserved ejection fraction (HFpEF) based on H2FPEF score.
- Documented sinus rhythm at screening by resting ECG and Holter.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.